Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1902 1
1919 1
1946 1
1947 1
1948 1
1949 1
1961 1
1965 1
1966 1
1976 2
1977 1
1983 3
1984 3
1987 3
1988 2
1989 3
1990 3
1991 2
1992 8
1993 5
1994 4
1995 6
1996 1
1997 6
1998 5
1999 10
2000 3
2001 4
2002 7
2003 5
2004 10
2005 7
2006 6
2007 11
2008 9
2009 3
2010 6
2011 9
2012 9
2013 13
2014 15
2015 21
2016 24
2017 31
2018 30
2019 18
2020 36
2021 32
2022 39
2023 3
Text availability
Article attribute
Article type
Publication date

Search Results

392 results
Results by year
Filters applied: . Clear all
Page 1
Venous Thromboembolism Risk With JAK Inhibitors: A Meta-Analysis.
Yates M, Mootoo A, Adas M, Bechman K, Rampes S, Patel V, Qureshi S, Cope AP, Norton S, Galloway JB. Yates M, et al. Among authors: cope ap. Arthritis Rheumatol. 2021 May;73(5):779-788. doi: 10.1002/art.41580. Epub 2021 Mar 25. Arthritis Rheumatol. 2021. PMID: 33174384
Ethical dilemmas and reflexivity in qualitative research.
Reid AM, Brown JM, Smith JM, Cope AC, Jamieson S. Reid AM, et al. Among authors: cope ac. Perspect Med Educ. 2018 Apr;7(2):69-75. doi: 10.1007/s40037-018-0412-2. Perspect Med Educ. 2018. PMID: 29536374 Free PMC article.
EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors.
Kostine M, Finckh A, Bingham CO, Visser K, Leipe J, Schulze-Koops H, Choy EH, Benesova K, Radstake TRDJ, Cope AP, Lambotte O, Gottenberg JE, Allenbach Y, Visser M, Rusthoven C, Thomasen L, Jamal S, Marabelle A, Larkin J, Haanen JBAG, Calabrese LH, Mariette X, Schaeverbeke T. Kostine M, et al. Among authors: cope ap. Ann Rheum Dis. 2021 Jan;80(1):36-48. doi: 10.1136/annrheumdis-2020-217139. Epub 2020 Apr 23. Ann Rheum Dis. 2021. PMID: 32327425 Free PMC article.
Endometriosis biomarkers of the disease: an update.
Encalada Soto D, Rassier S, Green IC, Burnett T, Khan Z, Cope A. Encalada Soto D, et al. Among authors: cope a. Curr Opin Obstet Gynecol. 2022 Aug 1;34(4):210-219. doi: 10.1097/GCO.0000000000000798. Curr Opin Obstet Gynecol. 2022. PMID: 35895963 Review.
T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4⁺ T cells.
Arbore G, West EE, Spolski R, Robertson AAB, Klos A, Rheinheimer C, Dutow P, Woodruff TM, Yu ZX, O'Neill LA, Coll RC, Sher A, Leonard WJ, Köhl J, Monk P, Cooper MA, Arno M, Afzali B, Lachmann HJ, Cope AP, Mayer-Barber KD, Kemper C. Arbore G, et al. Among authors: cope ap. Science. 2016 Jun 17;352(6292):aad1210. doi: 10.1126/science.aad1210. Science. 2016. PMID: 27313051 Free PMC article.
Interferon-α-mediated therapeutic resistance in early rheumatoid arthritis implicates epigenetic reprogramming.
Cooles FAH, Tarn J, Lendrem DW, Naamane N, Lin CM, Millar B, Maney NJ, Anderson AE, Thalayasingam N, Diboll J, Bondet V, Duffy D, Barnes MR, Smith GR, Ng S, Watson D, Henkin R, Cope AP, Reynard LN, Pratt AG; RA-MAP Consortium; Isaacs JD. Cooles FAH, et al. Among authors: cope ap. Ann Rheum Dis. 2022 Jun 9;81(9):1214-23. doi: 10.1136/annrheumdis-2022-222370. Online ahead of print. Ann Rheum Dis. 2022. PMID: 35680389 Free PMC article.
392 results